ECSP13012613A - Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol - Google Patents
Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipolInfo
- Publication number
- ECSP13012613A ECSP13012613A ECSP13012613A ECSP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A
- Authority
- EC
- Ecuador
- Prior art keywords
- gosipol
- copolymer
- producing
- carboximetilcellulose
- sound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/02—Alkyl or cycloalkyl ethers
- C08B11/04—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
- C08B11/10—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
- C08B11/12—Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
La invención se refiere al campo de la química orgánica, la farmacología y la medicina y se refiere a un método para producir un copolímero de carboximetilcelulosa sódica y gosipol, que tiene la fórmula (I), así como también su uso en una terapia compleja para pacientes con trastornos del espectro autista y alteraciones cognitivas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010141697/05A RU2453559C1 (ru) | 2010-10-11 | 2010-10-11 | Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP13012613A true ECSP13012613A (es) | 2013-10-31 |
Family
ID=45938511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP13012613 ECSP13012613A (es) | 2010-10-11 | 2013-05-09 | Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol |
Country Status (26)
Country | Link |
---|---|
US (1) | US9078916B2 (es) |
EP (1) | EP2628754B8 (es) |
JP (1) | JP5690944B2 (es) |
CN (1) | CN103189393B (es) |
AU (1) | AU2011314406B2 (es) |
BR (1) | BR112013008888B1 (es) |
CA (2) | CA2896450A1 (es) |
CL (2) | CL2013000962A1 (es) |
CO (1) | CO6731081A2 (es) |
CY (1) | CY1119413T1 (es) |
DK (1) | DK2628754T3 (es) |
EA (2) | EA024810B1 (es) |
EC (1) | ECSP13012613A (es) |
ES (1) | ES2643167T3 (es) |
GE (1) | GEP201706607B (es) |
HR (1) | HRP20171330T1 (es) |
HU (1) | HUE034920T2 (es) |
LT (1) | LT2628754T (es) |
PE (1) | PE20140200A1 (es) |
PL (1) | PL2628754T3 (es) |
PT (1) | PT2628754T (es) |
RS (1) | RS56257B1 (es) |
RU (1) | RU2453559C1 (es) |
SI (1) | SI2628754T1 (es) |
UA (2) | UA108126C2 (es) |
WO (1) | WO2012050483A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2499002C1 (ru) * | 2012-06-14 | 2013-11-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе |
RU2577539C2 (ru) * | 2014-06-17 | 2016-03-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе |
RU2754067C2 (ru) * | 2018-05-18 | 2021-08-25 | Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" | Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение |
RU2746504C1 (ru) * | 2020-02-27 | 2021-04-14 | Ниармедик Интернэшнл Лимитед | Противомикробные средства на основе бета-глюканов, способы их получения и применения |
JP7207364B2 (ja) | 2020-05-19 | 2023-01-18 | Jfeスチール株式会社 | ロッドミルのロッド交換装置及び方法 |
CN114622407B (zh) * | 2022-04-01 | 2023-09-19 | 浙江隆腾医用新材料有限公司 | 一种羧甲基纤维素钠纤维的洗脱方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2002755C1 (ru) * | 1991-02-04 | 1993-11-15 | Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН | Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием |
RU2222548C2 (ru) * | 2000-07-21 | 2004-01-27 | Зао "Ниармедик Плюс" | Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе |
AU2003247515A1 (en) * | 2002-06-10 | 2003-12-22 | Wyeth | Novel formate salt of o-desmethyl-venlafaxine |
DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
RU2238122C1 (ru) * | 2003-01-20 | 2004-10-20 | Ооо "Ниармедик Плюс" | Противоинфекционный фармацевтический препарат |
RU2270708C1 (ru) * | 2004-05-26 | 2006-02-27 | Ооо "Ниармедик Плюс" | Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний |
US20060144723A1 (en) * | 2004-11-02 | 2006-07-06 | Mary Fuller | Device for securing valuables |
US20070003621A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Dosage forms for movement disorder treatment |
US20090285865A1 (en) * | 2008-05-14 | 2009-11-19 | Shalaby Shalaby W | Palatable, solid oral formulations for male chemical sterilization |
-
2010
- 2010-10-11 RU RU2010141697/05A patent/RU2453559C1/ru active
-
2011
- 2011-06-10 UA UAA201305876A patent/UA108126C2/ru unknown
- 2011-10-06 JP JP2013533814A patent/JP5690944B2/ja not_active Expired - Fee Related
- 2011-10-06 LT LTEP11832823.6T patent/LT2628754T/lt unknown
- 2011-10-06 BR BR112013008888-5A patent/BR112013008888B1/pt not_active IP Right Cessation
- 2011-10-06 GE GEAP201113083A patent/GEP201706607B/en unknown
- 2011-10-06 RS RS20170877A patent/RS56257B1/sr unknown
- 2011-10-06 CN CN201180048898.4A patent/CN103189393B/zh not_active Expired - Fee Related
- 2011-10-06 AU AU2011314406A patent/AU2011314406B2/en not_active Ceased
- 2011-10-06 WO PCT/RU2011/000785 patent/WO2012050483A1/ru active Application Filing
- 2011-10-06 UA UAA201411350A patent/UA108975C2/ru unknown
- 2011-10-06 US US13/877,416 patent/US9078916B2/en not_active Expired - Fee Related
- 2011-10-06 CA CA2896450A patent/CA2896450A1/en not_active Abandoned
- 2011-10-06 EA EA201390530A patent/EA024810B1/ru active IP Right Revival
- 2011-10-06 ES ES11832823.6T patent/ES2643167T3/es active Active
- 2011-10-06 HU HUE11832823A patent/HUE034920T2/en unknown
- 2011-10-06 EP EP11832823.6A patent/EP2628754B8/en active Active
- 2011-10-06 DK DK11832823.6T patent/DK2628754T3/da active
- 2011-10-06 PE PE2013000829A patent/PE20140200A1/es active IP Right Grant
- 2011-10-06 PT PT118328236T patent/PT2628754T/pt unknown
- 2011-10-06 CA CA2811583A patent/CA2811583C/en not_active Expired - Fee Related
- 2011-10-06 PL PL11832823T patent/PL2628754T3/pl unknown
- 2011-10-06 SI SI201131286T patent/SI2628754T1/en unknown
- 2011-10-06 EA EA201690544A patent/EA031316B1/ru active IP Right Revival
-
2013
- 2013-04-10 CL CL2013000962A patent/CL2013000962A1/es unknown
- 2013-05-09 EC ECSP13012613 patent/ECSP13012613A/es unknown
- 2013-05-10 CO CO13117014A patent/CO6731081A2/es unknown
-
2015
- 2015-05-05 CL CL2015001180A patent/CL2015001180A1/es unknown
-
2017
- 2017-09-05 HR HRP20171330TT patent/HRP20171330T1/hr unknown
- 2017-09-14 CY CY20171100974T patent/CY1119413T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270619A1 (ru) | Применение бетанехола для лечения ксеростомии | |
DOP2017000013A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
CR20140512A (es) | Dispositivos y metodos para la fabricación de aditivos de componentes de implante | |
AU2012205878A8 (en) | miRNA for treating diseases and conditions associated with neo-angiogenesis | |
EA201171367A1 (ru) | Винилиндазолильные соединения | |
TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
CL2012000590A1 (es) | Proceso para preparar w-transaminasa (r)-selectiva. | |
BR112015020389A2 (pt) | compostos carbazol úteis como inibidores de bromodomínio | |
EA201400178A1 (ru) | Лечение рака молочной железы | |
UY33735A (es) | Compuestos antivirales | |
EA201490546A1 (ru) | Замещенные аннелированные пиримидины и их применение | |
GEP20156347B (en) | Benzodioxane inhibitors of leukotriene production | |
ECSP13012613A (es) | Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol | |
CU24263B1 (es) | Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer | |
CL2011002090A1 (es) | Complejo de haluro de agomelatina, que corresponde a un derivado de naftaleno; procedimiento de preparacion del mismo. | |
FI20115135A (fi) | Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus | |
EA201200046A1 (ru) | Новые соединения, фармацевтическая композиция и связанные с ними способы | |
MX2015014344A (es) | Terapia contra el cancer. | |
GT201200345A (es) | Compuestos heterocìclicos, su preparaciòn y su aplicaciòn terapèutica | |
ECSP14002542A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
DOP2015000176A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
UY34543A (es) | Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica. | |
EA201590656A1 (ru) | Азаиндолины | |
EA200970816A1 (ru) | Новая лекарственная форма | |
CO6670518A2 (es) | Tratamiento de infecciones de clostridium difícile en pacientes bajo terapia con antibióticos |